Topic:
Stem Cells
Latest Headlines
Latest Headlines
Pluristem's placental stem cells spur bone marrow growth
Pluristem Therapeutics' ($PSTI) special stem cells drawn from discarded placentas have shown major promise in a preclinical study. As the company announced today, they spurred hematopoietic stem cells to grow bone marrow in mice after their injection into muscle.
After death, some stem cells remain alive for days
By becoming dormant, skeletal muscle stem cells can survive in a human body after a person dies, for a good 17 days after the fact. During that time, it turns out, they're still viable enough to be revived and then subdivide into workable cells, Fabrice Chretien of the Pasteur Institute in Paris and his colleagues have discovered.
Stem cell pioneer Shinya Yamanaka splits $1.5M Millennium Technology Prize
Stem cell research pioneer Shinya Yamanaka is sharing this year's $1.5 million Millennium Technology Prize with Linus Torvalds, the creator of Linux.
Anti-rejection drug for bone marrow transplants to hit human trials by 2016
Armed with a new $6.8 million grant from the U.K.'s Wellcome Trust, Australian scientists are fine-tuning a drug designed to stop cancer patients from rejecting bone marrow transplants. Assuming they proceed on schedule, they hope to start human clinical trials by 2016, Sky News reports.
A special stem cell may cause deadly vascular disease
A newly discovered type of stem cell--multipotent vascular stem cells--may actually be the real factor behind vascular disease and the resulting heart attacks and strokes it typically can cause, University of California-Berkeley researchers have discovered.
Nanotech morphed stem cells into bone cells on command
Northwestern University scientists believe they have found a way to successfully use nanotechnology to directly induce stem cells to morph into bone cells, essentially on command.
Embryonic stem cells treat neuropathic pain in preclinical success
Stem cells have made another preclinical advance: In mice, they were used to successfully treat pain stemming from nerve injury, scientists at the University of California-San Francisco reveal.
Stem cell research advances in fits and starts
Twenty years after stem cell research seemed poised to change the world with the possibility of curing a wide range of diseases, and then struggled in fits and starts amid scientific and political obstacles, it is clearly morphing into new areas.
Stem cell research advances in fits and starts
Twenty years after stem cell research seemed poised to change the world with the possibility of curing a wide range of diseases, and then struggled in fits and starts amid scientific and political obstacles, it is clearly morphing into new areas.
Dangerous antipsychotic shows leukemia-fighting promise in mice
McMaster University researchers in Canada are confronting an interesting challenge: What do you do when a drug pulled from the market over safety concerns appears to display enormous promise in another indication? The issue is over thioridazine, an antipsychotic drug that drastically reduces leukemia stem cells in mice.
